The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.
wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Gene Review

CIMT  -  Carotid intimal medial thickness

Homo sapiens

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of CIMT

 

Psychiatry related information on CIMT

  • RESULTS: The cumulative dose of regular insulin showed a positive and significant relation with CIMT: increase of 21 microm in CIMT per S.D. of insulin use (95% CI: 8-35 adjusted for gender and age), which remained unchanged after adjustment for duration of diabetes, HbA1c, BMI, pulse pressure, physical activity and carotid lumen diameter [4].
  • In the current issue of the Journal, Van den Berkmortel and coworkers' report on the effect of smoking cessation on cardiovascular risk reduction, as estimated by assessment of progression of carotid intima-media thickness (CIMT) and arterial stiffness [5].
 

High impact information on CIMT

 

Chemical compound and disease context of CIMT

 

Biological context of CIMT

  • The majority of studies demonstrated increased CIMT in individuals with the MTHFR 677TT genotype [2].
  • The purpose of this study was to examine the relationship between carotid intima-media thickness (CIMT) inter-individual variability and 16 polymorphisms of 11 genes associated with cardiovascular risk factors (genes among lipid and homocysteine metabolisms, blood viscosity, platelet aggregation, leukocyte adhesion and renin-angiotensin system) [13].
  • 1. The aim of the present study was to investigate carotid intima-media thickness (CIMT) in relation to anthropometric, environmental and genetic factors, as well as cholesterol and blood pressure levels [14].
  • CIMT and MetS associations were evaluated with multivariable regression and area under receiver-operator characteristic curve (AUC) analyses [8].
  • Carotid artery intimal medial thickness (CIMT) and brachial artery flow-mediated vasodilation (FMD) are ultrasound imaging based surrogate markers of cardiovascular risk [15].
 

Anatomical context of CIMT

 

Associations of CIMT with chemical compounds

  • METHODS: We searched literature databases for articles examining homocysteine and CIMT published before September 2003 [2].
  • Folate status showed no relation to CIMT [2].
  • Associations between CIMT and polymorphisms in the apolipoprotein CIII, cholesteryl ester transfer protein, methylene tetrahydrofolate reductase and fibrinogen genes were observed and explained approximately 20% of CIMT variation in men [14].
  • The mean rate of CIMT change was 31% lower in women assigned to troglitazone (P = 0.048) [3].
  • We tested the effects of treatment with a thiazolidinedione drug on rates of progression of carotid intima-media thickness (CIMT) and some putative determinants of CIMT in young women at high risk for type 2 diabetes [3].
 

Regulatory relationships of CIMT

  • CONCLUSIONS: This large family study shows that the rare T allele at the C538T polymorphism of LEP substantially influences pulse pressure and CIMT, but does not appear to exert this effect through actions on plasma leptin level or BMI [20].
 

Other interactions of CIMT

  • The association of the 677 C--> T MTHFR polymorphism with CIMT further supports this finding [2].
  • There was no association between CIMT and any CRP gene polymorphism in either population [21].
  • Statistical analyses were carried out by ANOVA, after adjustment of CIMT for age, body mass index, and smoking, and by multiple regression analyses [13].
  • The CIMT of renal transplant patients was similar in IL-10 (-819, -592) and TNF-alpha (-308, -238) genotypes [22].
  • Right and left CIMT were higher in TT genotype (n = 16) than CT (n = 46) and CC (n = 10) genotypes of TGF-beta1 codon 10 (T-->C) gene polymorphism (RCIMT, 7.7 +/- 2.2 mm vs. 7.0 +/- 1.4 mm vs. 5.9 +/- 1.4 mm, P = 0.025; LCIMT, 8.5 +/- 2.5 mm vs. 7.0 +/- 1.3 mm vs. 6.1 +/- 1.2 mm, P = 0.002) [22].
 

Analytical, diagnostic and therapeutic context of CIMT

  • CIMT was measured by high resolution B-mode ultrasonography in an healthy population of 77 men and 84 women, aged 35-54 years and selected from a French Cohort: the Stanislas Cohort [13].
  • Nishimura (Chicago, USA), were "cellular therapies" and "vaccination against cancer". The lectures selected for this report aim to provide an overview of the complete scientific program and give an impression of the lively atmosphere that could be felt from the first until the last session of CIMT 2005 [23].
  • Subsequently, CIMT has been a valuable research tool in clinical trials in the assessment of therapeutic agents directed against atherosclerosis [24].
  • Intervention studies have shown that modification of CHD risk factors can significantly reduce progression of CIMT [25].
  • The mean CIMT in patients and control group were 0.79 +/- 0.16 mm and 0.54 +/- 0.09 mm, respectively [26].

References

  1. Non-invasively measured structural and functional arterial characteristics and coronary heart disease risk in middle aged and elderly men. van Trijp, M.J., Bos, W.J., van der Schouw, Y.T., Muller, M., Grobbee, D.E., Bots, M.L. Atherosclerosis (2006) [Pubmed]
  2. Homocysteine and carotid intima-media thickness: a critical appraisal of the evidence. Durga, J., Verhoef, P., Bots, M.L., Schouten, E. Atherosclerosis (2004) [Pubmed]
  3. Effect of thiazolidinedione treatment on progression of subclinical atherosclerosis in premenopausal women at high risk for type 2 diabetes. Xiang, A.H., Peters, R.K., Kjos, S.L., Ochoa, C., Marroquin, A., Goico, J., Tan, S., Wang, C., Azen, S.P., Liu, C.R., Liu, C.H., Hodis, H.N., Buchanan, T.A. J. Clin. Endocrinol. Metab. (2005) [Pubmed]
  4. High cumulative insulin exposure: a risk factor of atherosclerosis in type 1 diabetes? Muis, M.J., Bots, M.L., Bilo, H.J., Hoogma, R.P., Hoekstra, J.B., Grobbee, D.E., Stolk, R.P. Atherosclerosis (2005) [Pubmed]
  5. Use of intermediate cardiovascular endpoints in intervention studies: not as easy as it seems? Bots, M.L. The Netherlands journal of medicine. (2004) [Pubmed]
  6. Associations of postmenopausal estrogen use with cardiovascular disease and its risk factors in older women. The CHS Collaborative Research Group. Manolio, T.A., Furberg, C.D., Shemanski, L., Psaty, B.M., O'Leary, D.H., Tracy, R.P., Bush, T.L. Circulation (1993) [Pubmed]
  7. Risk factor groupings related to insulin resistance and their synergistic effects on subclinical atherosclerosis: the atherosclerosis risk in communities study. Golden, S.H., Folsom, A.R., Coresh, J., Sharrett, A.R., Szklo, M., Brancati, F. Diabetes (2002) [Pubmed]
  8. Increased subclinical atherosclerosis in young adults with metabolic syndrome: the Bogalusa Heart Study. Tzou, W.S., Douglas, P.S., Srinivasan, S.R., Bond, M.G., Tang, R., Chen, W., Berenson, G.S., Stein, J.H. J. Am. Coll. Cardiol. (2005) [Pubmed]
  9. Effect of lipid modification on progression of coronary calcification. McCullough, P.A. J. Am. Soc. Nephrol. (2005) [Pubmed]
  10. Vascular function and carotid intimal-medial thickness in children with insulin-dependent diabetes mellitus. Singh, T.P., Groehn, H., Kazmers, A. J. Am. Coll. Cardiol. (2003) [Pubmed]
  11. Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitus. Esposito, K., Giugliano, D., Nappo, F., Marfella, R. Circulation (2004) [Pubmed]
  12. Carotid artery intimal-medial thickness: indicator of atherosclerotic burden and response to risk factor modification. Mukherjee, D., Yadav, J.S. Am. Heart J. (2002) [Pubmed]
  13. APOC3, CETP, fibrinogen, and MTHFR are genetic determinants of carotid intima-media thickness in healthy men (the Stanislas cohort). Pallaud, C., Sass, C., Zannad, F., Siest, G., Visvikis, S. Clin. Genet. (2001) [Pubmed]
  14. Environmental and genetic determinants of intima-media thickness of the carotid artery. Zannad, F., Sass, C., Visvikis, S. Clin. Exp. Pharmacol. Physiol. (2001) [Pubmed]
  15. Carotid artery intimal medial thickness, brachial artery flow-mediated vasodilation and cardiovascular risk factors in diabetic and non-diabetic indigenous Australians. Chan, L., Shaw, A.G., Busfield, F., Haluska, B., Barnett, A., Kesting, J., Short, L., Marczak, M., Shaw, J.T. Atherosclerosis (2005) [Pubmed]
  16. Evaluation of carotid artery and aortic intima-media thickness measurements for exclusion of significant coronary atherosclerosis in patients scheduled for heart valve surgery. Belhassen, L., Carville, C., Pelle, G., Monin, J.L., Teiger, E., Duval-Moulin, A.M., Dupouy, P., Dubois Rande, J.L., Gueret, P. J. Am. Coll. Cardiol. (2002) [Pubmed]
  17. Carotid intima-media thickness and the risk of new vascular events in patients with manifest atherosclerotic disease: the SMART study. Dijk, J.M., van der Graaf, Y., Bots, M.L., Grobbee, D.E., Algra, A. Eur. Heart J. (2006) [Pubmed]
  18. Hemoglobin and atherosclerosis in patients with manifest arterial disease The SMART-study. Dijk, J.M., Wangge, G., Graaf, Y., Bots, M.L., Grobbee, D.E., Algra, A. Atherosclerosis (2006) [Pubmed]
  19. Long-term effect of estrogen replacement on plasma nitric oxide levels: results from the estrogen in the prevention of atherosclerosis trial (EPAT). Hwang, J., Mack, W.J., Xiang, M., Sevanian, A., Lobo, R.A., Hodis, H.N. Atherosclerosis (2005) [Pubmed]
  20. A rare variant of the leptin gene has large effects on blood pressure and carotid intima-medial thickness: a study of 1428 individuals in 248 families. Gaukrodger, N., Mayosi, B.M., Imrie, H., Avery, P., Baker, M., Connell, J.M., Watkins, H., Farrall, M., Keavney, B. J. Med. Genet. (2005) [Pubmed]
  21. Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events. Lange, L.A., Carlson, C.S., Hindorff, L.A., Lange, E.M., Walston, J., Durda, J.P., Cushman, M., Bis, J.C., Zeng, D., Lin, D., Kuller, L.H., Nickerson, D.A., Psaty, B.M., Tracy, R.P., Reiner, A.P. JAMA (2006) [Pubmed]
  22. Impact of cytokine gene polymorphism on cardiovascular risk in renal transplant recipients. Altun, B., Yilmaz, R., Kahraman, S., Gençtoy, G., Arici, M., Onalan, O., Oto, A., Hayran, M., Bakkaloğlu, M., Yasavul, U., Turgan, C. Transpl. Int. (2005) [Pubmed]
  23. Cancer immunotherapy 2005: Mainz, Germany, 12-13 May 2005. Britten, C.M., Gouttefangeas, C., Kreiter, S. Cancer Immunol. Immunother. (2006) [Pubmed]
  24. Clinical value of carotid intima-media thickness testing. Devine, P.J., Carlson, D.W., Taylor, A.J. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology. (2006) [Pubmed]
  25. Intima media thickness as a surrogate marker for generalised atherosclerosis. Bots, M.L., Grobbee, D.E. Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy. (2002) [Pubmed]
  26. Increased incidence of carotid artery wall changes and associated variables in hemodialysis patients without symptomatic cardiovascular disease. Kiykim, A.A., Camsari, A., Kahraman, S., Arici, M., Altun, B., Cicek, D., Erdem, Y., Yasavul, U., Turgan, C., Cağlar, S., Oto, A. Yonsei Med. J. (2004) [Pubmed]
 
WikiGenes - Universities